代表性论文、代表项目、代表性成果奖励等

1、Zhufeng Wang, …, Mei Jiang(Corresponding), et al. Eosinophilia and Lung Cancer: Analysis From Real-World Data and Mendelian Randomization Study. Front Med (Lausanne). 2022 Mar 9;9:830754. doi: 10.3389/fmed.2022.830754. eCollection 2022. (IF= 5.091)

2、Hanwen Liang, …, Mei Jiang(Corresponding), et al. Risk factors of chronic cough in China: a systematic review and meta-analysis. Expert Rev Respir Med. 2022 Mar 28;1-12. doi: 10.1080/17476348.2022.2049759. (IF= 3.772)

3、Hanwen Liang, …, Mei Jiang(Corresponding), et al. Prevalence of chronic cough in China: A systematic review and meta-analysis. BMC Pulm Med. 2022 Feb 12;22(1):62. doi: 10.1186/s12890-022-01847-w. (IF= 3.317)

4、Rundong Qin, …, Mei Jiang(Corresponding), et al. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID‑19 Infection: a Systematic Review and Meta‑analysis. Clin Rev Allergy Immunol. 2022 Jan 18;1-33. doi: 10.1007/s12016-021-08908-8. (IF= 8.667)

5、Sabine Schmid, Mei Jiang(Co-first), …, et al. Accounting for EGFR mutations in epidemiological analyses of non-small cell lung cancers: Examples based on the International Lung Cancer Consortium data. Cancer Epidemiol Biomarkers Prev. 2022 Mar 1;31(3):679-687. doi: 10.1158/1055-9965.EPI-21-0747. (IF= 4.254)

6、Liang J, …, Jiang M(Corresponding), et al. Rigorous Assessment of Guidelines on COVID-19-Related Thrombotic or Thromboembolic Disease: Implications for Clinical Practice of Prevention, Diagnosis, and Treatment. Evid Based Complement Alternat Med. 2021:5513744. doi: 10.1155/2021/5513744. eCollection 2021. (IF= 2.621)

7、Xie J, …, Mei Jiang(Corresponding), et al.. Critical Review of the Scientific Evidence and Recommendations in COVID-19 Management Guidelines. Open Forum Infect Dis. 2021;8(8):ofab376. doi: 10.1093/ofid/ofab376. (IF= 3.833)

8、Liang J, …, Mei Jiang(Corresponding), et al. Epidemiology and co-infection patterns in patients with respiratory tract infections in southern China between 2018 and 2020. J Infect. 2021;83(3):e6-e8. doi: 10.1016/j.jinf.2021.07.013. (IF= 6.073)

9、Xiangwei Zou, …, Mei Jiang(Co-Corresponding), et al. Serum levels of specific immunoglobulin E to Dermatophagoides pteronyssinus allergen components in patients with allergic rhinitis or/and asthma. Allergy Asthma Proc. 2021;42(1):e40-e46. doi: 10.2500/aap.2021.42.200105. (IF= 2.583)

10、Kai-Rui Wan, …, Mei Jiang(Corresponding), et al. Quality changes of clinical practice guidelines for respiratory diseases in China: A systematic review. Clin Respir J. 2021. doi: 10.1111/crj.13402. (IF= 2.572)  

11、Mei Jiang, …, et al.. The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients. Lung Cancer. 2021;152:58-65. doi: 10.1016/j.lungcan.2020.11.029. (IF= 5.704)

12、Wang Z, …, Mei Jiang(Corresponding), et al. The use of non-invasive ventilation in COVID-19: A systematic review. Int J Infect Dis. 2021;106:254-261. doi: 10.1016/j.ijid.2021.03.078. (IF= 3.622)

13、Wang Z, …, Mei Jiang(Corresponding), et al.  Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: A systematic review and meta-analysis without cases duplication. Medicine (Baltimore). 2020;99(48):e23327. doi: 10.1097/MD.0000000000023327. (IF= 1.881)

14、Ruchong Chen, Ling Sang, Mei Jiang(Co-first),…,et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020 Jul;146(1):89-100. doi: 10.1016/j.jaci.2020.05.003. (IF= 10.790)

15、Chen R, Liang W, Jiang M(Co-first), …,et al. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020 Jul;158(1):97-105. doi: 10.1016/j.chest.2020.04.010. (IF= 9.410)

16、Zhan W, Zhang L, Jiang M(Co-first), …,et al. A new simple score of chronic cough: cough evaluation test. BMC Pulm Med. 2020 Mar 20;20(1):68. doi: 10.1186/s12890-020-1106-1. (IF= 3.310)

17、Wan K, …, Jiang M (Corresponding). A Quality Assessment of Evidence-based Guidelines for the Prevention and Control of Ventilator-associated Pneumonia: A Systematic Review. J Thorac Dis. 2019;11(7):2795-2807. doi: 10.21037/jtd.2019.06.56. (IF= 2.892)

18、Jiang M, …,et al. Methodology for development of the Chinese evidence-based Clinical Practice Guideline of the Diagnosis and Management of Cough. J Thorac Dis. 2018;10(11):6310-6313. doi: 10.21037/jtd.2018.09.154. (IF= 2.027) 

19、Jiang M, …,et al. A critical review of the quality of cough clinical practice guidelines. Chest. 2016; 150(4):777-788. (IF=9.411)

20、Guan WJ, Jiang M(Co-first), …,et al. In Reply: Towards precision medicine: phenotyping bronchiectasis with unsupervised learning technique. Int J Tuberc Lung Dis. 2016 May;20(5):710. doi: 10.5588/ijtld.16.0194-2. (IF:2.373)

21、Guan WJ, Jiang M(Co-first), …,et al. Unsupervised learning technique identifies bronchiectasis phenotypes with distinct clinical characteristics. Int J Tubercul Lung Dis. 2016 Mar;20(3):402-10. doi: 10.5588/ijtld.15.0500. (IF=2.373)

22、Zhang Y, Jiang M(Co-first), …,et al. Chromosome 15q25 (CHRNA3-CHRNB4) variation indirectly impacts lung cancer risk in Chinese males. Plos one. 2016 Mar 4;11(3):e0149946. doi: 10.1371/journal.pone.0149946. eCollection 2016. (IF=3.241)

23、Jiang M, …,et al. Spirometric Reference Values for Healthy Han Children Aged 5–15 Years in Guangzhou, Southern China. Pediatr Pulmonol. 2015; 50(10):1009-16. doi: 10.1002/ppul.23099. (IF=3.034)

24、Jiang M, …,et al. The quality assessment of clinical practice guidelines for respiratory diseases in China: A systematic appraisal.Chest. 2015;148(3):759-66. doi: 10.1378/chest.14-3201. (IF=9.411)

25、Tang Y, Jiang M(Co-first), …,et al. Association between awareness of smoking and smoking cessation advice provided by hospital chest physicians in Guangzhou, China: a multi-institutional cross-sectional survey. Respirology.2013. doi: 10.1111/resp.12091. (IF=6.422)